Differentiated Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2008-08-12FDA Approved: THYROGEN — Supplemental Application (Genzyme Corporation)
FDA approved a supplemental labeling for THYROGEN (thyrotropin alfa) by Genzyme Corporation, expanding/modifying its indications for use in …
-
FDA label_change · 2008-01-17FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for HICON (Sodium Iodide I-131) from Jubilant Radiopharma, updating its labeling.